
Tema Heart & Health ETF
HRTSNASDAQTemaEquity
As of Nov 16, 2026 close
- Assets (AUM)
- $53.10M
- Expense ratio
- 0.75%
- Dividend yield
- 1.22%
- Holdings
- 48
- 52-week range
- $32.59$39.92
- Volume (live)
- -
- Avg. volume (3M)
- 2.05K
HRTS ETF: Tema Heart & Health ETF - Price, Holdings & Analysis
Tema Heart & Health ETF Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
| Day's Range | $38.77 - $39.49 |
|---|---|
| 52-Week High | $39.92 |
| 52-Week Low | $32.59 |
| Open | $39.49 |
| Volume (last close) | 2.50K |
| Average Volume (3M) | 2.05K |
| 1 Day Change | −1.22% |
|---|---|
| 1 Month Change | +5.05% |
| 6 Month Change | +16.29% |
| YTD Change | +9.60% |
| 1 Year Change | +12.68% |
| Annual Dividend | $0.47 |
|---|---|
| Dividend Yield | 1.22% |
| Last Dividend Ex-Date | Dec 10, 2025 |
| Dividend Growth YoY | +0.79% |
| Years Dividend Growth | 1 |
| Assets (AUM) | $53.10M |
|---|---|
| Expense Ratio | 0.75% |
| Total Holdings | 48 |
| Inception Date | Nov 19, 2023 |
| 50-Day MA | $37.18 |
|---|---|
| 200-Day MA | $35.71 |
| RSI | 55.26 |
| Stochastic %K | 52.77 |
| Stochastic %D | 63.22 |
Source: Exchange price data and fund disclosures. Data as of Nov 16, 2026. Data sources and methodology
HRTS at a Glance
Tema Heart & Health ETF (HRTS) is an equity ETF from Tema, launched in November 2023. It manages $53.10M in assets and charges a 0.75% expense ratio, about $75 a year per $10,000 invested.
Based on holdings data updated Nov 14, 2026, it holds 48 positions. The largest are Eli Lilly and Company (LLY, 12.61%), Thermo Fisher Scientific Inc. (TMO, 5.40%) and Roche Holding AG (OTC:RHHBY, 4.29%). The top 10 holdings make up 47.1% of the fund. By sector it leans toward Healthcare (100.0%). Its largest country exposures are United States (78.5%), Switzerland (7.8%) and Denmark (4.3%).
It pays distributions yielding 1.22% at the Nov 16, 2026 close, $0.47 per share over the trailing 12 months. As of the Nov 16, 2026 close, the share price is up 12.7% over one year (price change, excluding distributions).
Frequently Asked Questions About Tema Heart & Health ETF
What is the current price of HRTS?
The latest HRTS price is $38.77 (Nov 16, 2026 close). The 52-week range is $32.59–$39.91. The share price is up 12.7% over the past year (price change, excluding distributions).
What is the expense ratio for HRTS?
HRTS's annual expense ratio is 0.75%, about $75 a year for every $10,000 invested.
Does HRTS pay dividends?
Yes, HRTS pays a 1.22% dividend yield (trailing 12 months, at the Nov 16, 2026 close). The most recent ex-dividend date was December 10, 2025. View full dividend history in the Dividends section.
What are the top holdings of HRTS?
In holdings data last updated Nov 14, 2026, HRTS's largest holdings are Eli Lilly and Company (12.6%), Thermo Fisher Scientific Inc. (5.4%), Roche Holding AG (4.3%) (combined weight: 22.3%). The fund holds 48 total positions. View the complete portfolio breakdown in the Holdings section.
How concentrated is HRTS's portfolio?
In holdings data updated Nov 14, 2026, the top 10 holdings make up 47.1% of HRTS's assets across 48 positions. Its largest sector weight is Healthcare at 100.0%.
How large is HRTS and when did it launch?
HRTS manages $53.10M in assets. Tema launched the fund on November 19, 2023, about 2 years before the Nov 16, 2026 close.